Literature DB >> 6776529

Partial sequence of human complement component factor B: novel type of serine protease.

D L Christie, J Gagnon, R R Porter.   

Abstract

Factor B (a component of the alternative pathway of complement) is believed to contain the proteolytic site of the complex enzymes C3 convertase (C3bB) and C5 convertase (C3bnB). Conflicting results have been obtained in regard to the inactivation of these enzymes by diisopropyl phosphorofluoridate but it has been suggested that activated Factor B (Factor B) is a serine protease with the active site in Bb, a COOH-terminal fragment of approximately 60,000 molecular weight. Partial amino acid sequence studies of Bb derived from human Factor B have shown that the NH2-terminal 40 residues have no homology with NH2-terminal sequences of other serine proteases. However, positioning of a further 170 residues out of approximately 290 residues in two continuous CNBr fragments from the COOH terminus has shown that there is a strong homology of sequence in this section. The active site residues histidine, aspartic acid, and serine all are present in positions corresponding with those of typical serine proteases. It is suggested that Factor B is a novel type of serine protease with a catalytic chain of molecular weight twice that of proteases previously studied and probably with a different activation mechanism.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776529      PMCID: PMC349961          DOI: 10.1073/pnas.77.8.4923

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  The serine protease nature of the C3 and C5 convertases of the classical and alternative complement pathways.

Authors:  R G Medicus; O Götze; H J Müller-Eberhard
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

2.  Role of proteolytic enzymes in biological regulation (a review).

Authors:  H Neurath; K A Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

3.  Complement activation by the properdin system: formation of a stoichiometric. C3 cleaving complex of properdin factor B with C36.

Authors:  W Vogt; W Dames; G Schmidt; L Dieminger
Journal:  Immunochemistry       Date:  1977-03

4.  Specific cleavage between variable and constant domains of rabbit antibody light chains by dilute acid hydrolysis.

Authors:  K J Fraser; K Pulsen; E Haber
Journal:  Biochemistry       Date:  1972-12-19       Impact factor: 3.162

5.  Chymotrypsinogen: 2.5-angstrom crystal structure, comparison with alpha-chymotrypsin, and implications for zymogen activation.

Authors:  S T Freer; J Kraut; J D Robertus; H T Wright; N H Xuong
Journal:  Biochemistry       Date:  1970-04-28       Impact factor: 3.162

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 7.  The alternative pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  Adv Immunol       Date:  1976       Impact factor: 3.543

8.  Sequence of the amino-terminal 349 residues of rabbit muscle glycogen phosphorylase including the sites of covalent and allosteric control.

Authors:  A Koide; K Titani; L H Ericsson; S Kumar; H Neurath; K A Walsh
Journal:  Biochemistry       Date:  1978-12-26       Impact factor: 3.162

9.  Third component of human complement: purification from plasma and physicochemical characterization.

Authors:  B D Tack; J W Prahl
Journal:  Biochemistry       Date:  1976-10-05       Impact factor: 3.162

10.  Enzymatic conversion of proteins to glycoproteins by lipid-linked saccharides: a study of potential exogenous acceptor proteins.

Authors:  K E Kronquist; W J Lennarz
Journal:  J Supramol Struct       Date:  1978
View more
  16 in total

1.  Amino acid sequence of the Bb fragment from human complement Factor B. Alignment of the cyanogen bromide-cleavage peptides.

Authors:  J Gagnon; D L Christie
Journal:  Biochem J       Date:  1983-01-01       Impact factor: 3.857

Review 2.  Molecular genetics of the major histocompatibility linked complement genes.

Authors:  H R Colten
Journal:  Springer Semin Immunopathol       Date:  1983

3.  Isolation, characterization and N-terminal sequences of the CNBr-cleavage peptides from human complement Factor B. Localization of a free thiol group and a sequence defining the site cleaved by factor D.

Authors:  D L Christie; J Gagnon
Journal:  Biochem J       Date:  1982-03-01       Impact factor: 3.857

4.  Isolation of cDNA clones for the human complement protein factor B, a class III major histocompatibility complex gene product.

Authors:  D E Woods; A F Markham; A T Ricker; G Goldberger; H R Colten
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

5.  The effects of iodine and thiol-blocking reagents on complement component C2 and on the assembly of the classical-pathway C3 convertase.

Authors:  M A Kerr; C Parkes
Journal:  Biochem J       Date:  1984-04-15       Impact factor: 3.857

6.  Human complement component C4. Structural studies on the fragments derived from C4b by cleavage with C3b inactivator.

Authors:  E M Press; J Gagnon
Journal:  Biochem J       Date:  1981-11-01       Impact factor: 3.857

7.  New synthetic inhibitor to the alternative complement pathway.

Authors:  N Ikari; Y Sakai; Y Hitomi; S Fujii
Journal:  Immunology       Date:  1983-08       Impact factor: 7.397

8.  The reaction of iodine and thiol-blocking reagents with human complement components C2 and factor B. Purification and N-terminal amino acid sequence of a peptide from C2a containing a free thiol group.

Authors:  C Parkes; J Gagnon; M A Kerr
Journal:  Biochem J       Date:  1983-07-01       Impact factor: 3.857

9.  The activation of the alternative pathway C3 convertase by human plasma kallikrein.

Authors:  R G DiScipio
Journal:  Immunology       Date:  1982-03       Impact factor: 7.397

10.  The conversion of human complement component C5 into fragment C5b by the alternative-pathway C5 convertase.

Authors:  R G DiScipio
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.